Skip to main content

Advertisement

Log in

Optimal timing of anticoagulation pre- and post-colonoscopy with polypectomy

  • Original Article
  • Published:
Techniques in Coloproctology Aims and scope Submit manuscript

Abstract

Purpose

An increasing number of patients are treated with anticoagulation for many medical conditions. Our practice is to suspend warfarin 5–7 days, aspirin 3 days, and clopidogrel (Plavix) 7 days prior to colonoscopy that may require polypectomy. Generally, we accept an INR of ≤1.5 as safe. However, there are no published case series documenting when it is safe to resume these medications after polypectomy. Therefore, the management of anticoagulation after polypectomy varies. We sought to evaluate the safety of our practice with regard to anticoagulation and polypectomy.

Methods

We conducted a retrospective review of all patients over the age of 18 who underwent colonoscopy with polypectomy while on anticoagulation for various medical comorbidities at our institution over a 15-month period (July 2007 to September 2008). All morbidity and mortality that occurred for the first 3 weeks post-polypectomy was recorded. The Mann–Whitney test was performed using SPSS 15.5.

Results

From July 2007 to September 2008, we performed 579 colonoscopies with polypectomy on patients who were on anticoagulation therapy during the study period. Seven (1.2%) patients presented to the Emergency Room or were hospitalized within 3 weeks after polypectomy for lower gastrointestinal bleeding. Distribution of anticoagulants was listed: 2 (28.6%) patients on warfarin, 4 (57.1%) on aspirin, and 1 (14.3%) on clopidogrel. Warfarin was held for, on average, 4 days pre-polypectomy and 1 day post-polypectomy. Aspirin was held, on average, 3 days both pre- and post-polypectomy. Clopidogrel was held, on average 6.5 days pre-polypectomy but restarted immediately post-polypectomy. No statistically significant difference was found between the number of days that anticoagulation was held pre- or post-polypectomy in individuals who did and did not bleed.

Conclusion

We found that our practice of resuming anticoagulation or antiplatelet agents (warfarin, aspirin, and clopidogrel) post-polypectomy was safe and did not prove to significantly affect the post-polypectomy rate of hemorrhage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rex DK, Johnson DA, Anderson JC et al (2009) American College of Gastroenterology guidelines for colorectal cancer screening 2009. Am J Gastroenterol 104:739–750

    Article  PubMed  Google Scholar 

  2. Seeff LC, Richards TB, Shapiro JA et al (2004) How many endoscopies are performed for colorectal cancer screening? Results from CDC’s survey of endoscopic capacity. Gastroenterology 127:1670–1677

    Article  PubMed  Google Scholar 

  3. Lee SY, Tang SJ, Rockey DC et al, Korean Association for the Study of Intestinal Disease (2008) Managing anticoagulation and antiplatelet medications in GI endoscopy: a survey comparing the East and the West. Gastrointest Endosc 67:1076–1081

    Google Scholar 

  4. Rosen L, Bub DS, Reed JF III, Natasee SA (1993) Hemorrhage following colonoscopic polypectomy. Dis Colon Rectum 36:1126–1131

    Article  PubMed  CAS  Google Scholar 

  5. Hui AJ, Wong RM, Ching J, Hung LC, Chung SC, Sung JJ (2004) Risk of colonoscopic polypectomy bleeding with anticoagulants and antiplatelet agents: analysis of 1657 cases. Gastrointest Endosc 59:44–48

    Article  PubMed  Google Scholar 

  6. Gibbs DH, Opelka FG, Beck DE, Hicks TC, Timmcke AE, Gathright JB Jr (1996) Postpolypectomy colonic hemorrhage. Dis Colon Rectum 39:806–810

    Article  PubMed  CAS  Google Scholar 

  7. Eisen GM, Baron TH, Dominitz JA et al, American Society for Gastrointestinal Endoscopy (2002) Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastrointest Endosc 55:775–779

    Google Scholar 

  8. Yousfi M, Gostout CJ, Baron TH et al (2004) Postpolypectomy lower gastrointestinal bleeding: potential role of aspirin. Am J Gastroenterol 99:1785–1789

    Article  PubMed  Google Scholar 

  9. Witt DM, Delate T, McCool KH et al, WARPED Consortium (2009) Incidence and predictors of bleeding or thrombosis after polypectomy in patients receiving and not receiving anticoagulation therapy. J Thromb Haemost 7:1982–1989

    Google Scholar 

  10. Friedland S, Sedehi D, Soetikno R (2009) Colonoscopic polypectomy in anticoagulated patients. World J Gastroenterol 15:1973–1976

    Article  PubMed  Google Scholar 

  11. Shiffman ML, Farrel MT, Yee YS (1994) Risk of bleeding after endoscopic biopsy or polypectomy in patients taking aspirin or other NSAIDS. Gastrointest Endosc 40:458–462

    Article  PubMed  CAS  Google Scholar 

  12. Hittelet A, Deviere J (2003) Management of anticoagulants before and after endoscopy. Can J Gastroenterol 17:329–332

    PubMed  Google Scholar 

  13. Kim HS, Kim TI, Kim WH et al (2006) Risk factors for immediate postpolypectomy bleeding of the colon: a multicenter study. Am J Gastroenterol 101:1333–1341

    Article  PubMed  Google Scholar 

Download references

Disclosure

The Authors have no relevant financial relationships.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to I. T. Khubchandani.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Khubchandani, I.T., Heyrosa, M.G. & Thekkeurumbil, S.V. Optimal timing of anticoagulation pre- and post-colonoscopy with polypectomy. Tech Coloproctol 15, 185–189 (2011). https://doi.org/10.1007/s10151-010-0668-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10151-010-0668-y

Keywords

Navigation